Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Range Cancer Therapeutics Index (NQ: CNCR )

14.35 +0.17 (+1.20%)
Official Closing Price Updated: 1:15 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 956
Open 14.34
Bid (Size) 10.65 (2)
Ask (Size) 15.65 (5)
Prev. Close 14.18
Today's Range 14.23 - 14.35
52wk Range 10.78 - 17.96
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Top-Ranked ETFs Under $20 For Your Portfolio
Let us dig into some of the ETFs that are below $20 and have a strong buy rating. These low-priced ETFs could lead to huge gains in the coming months based on market trends. 
Via Talk Markets
Topics ETFs
5 Market-Beating Sector ETFs Of Q1
Here are some of the top performers in the ETF space from different sectors of the market. 
Via Talk Markets
Topics ETFs

Performance

YTD
+5.21%
+5.21%
1 Month
-1.58%
-1.58%
3 Month
-1.24%
-1.24%
6 Month
-2.65%
-2.65%
1 Year
+26.77%
+26.77%

More News

Read More
5 Sector ETFs Beating The Market Halfway Through Q1
Via Talk Markets
Topics ETFs
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023
Via Talk Markets
5 ETFs Riding High On The Biotech Comeback
Via Talk Markets
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
Via Talk Markets
Best Biotech Stocks & ETFs for mRNA, Gene Editing
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS